Johnson & Johnson expects full-year earnings in the range of $10.50 to $10.70 per share, with revenue in the range of $91 billion to $91.8 billion. This story was generated by Automated Insights ( ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Products made here might still depend on materials from overseas. And they might be made on machines needing foreign replacement parts.

A judge rejected Johnson & Johnson’s proposed $9 billion settlement to end lawsuits claiming its talc-based products caused ovarian cancer.

Meanwhile, Johnson & Johnson, a global drugmaker based in New Brunswick, announced plans in March to spend $55 billion over the next four years on domestic manufacturing, research and technology ...

The teenager, 16, was taken to Robert Wood Johnson Hospital in New Brunswick, where he was pronounced dead. Police said ...

New Brunswick-based Johnson & Johnson announced plans in March to spend $55 billion over the next four years on domestic manufacturing, research and technology, including a $2 billion North ...

Readers learn about the life of a family of farmers in the early 19th century in New Hampshire in "Ox-Cart Man." The book was ...

The teenager was shot about a mile from Rutgers University; however, it was unclear if the investigation impacted students ...